The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial
Abstract
A beneficial effect of recombinant activated factor VII (rFVIIa) in Child-Pugh class B and C patients with cirrhosis who have variceal bleeding has been suggested. This randomized controlled trial assessed the efficacy and safety of rFVIIa in patients with advanced cirrhosis and active variceal bleeding. At 31 hospitals in an emergency setting, 256 patients (Child-Pugh > 8; Child-Pugh B = 26%, C = 74%) were randomized equally to: placebo; 600 μg/kg rFVIIa (200 + 4× 100 μg/kg); or 300 μg/kg rFVIIa (200 + 100 μg/kg). Dosing was intravenous at 0, 2, 8, 14, and 20 hours after endoscopy, in addition to standard vasoactive, prophylactic antibiotic, and endoscopic treatment. The primary composite endpoint consisted of failure to control 24-hour bleeding, or failure to prevent rebleeding or death at day 5. Secondary endpoints included adverse events and 42-day mortality. Baseline characteristics were comparable between groups. Administration of rFVIIa had no significant effect on the composite endpoint compared with placebo ( P = 0.37). There was no significant difference in 5-day mortality between groups; however, 42-day mortality was significantly lower with 600 μg/kg rFVIIa compared with placebo (odds ratio 0.31, 95% confidence interval = 0.13–0.74), and bleeding-related deaths were reduced from 12% (placebo) to 2% (600 μg/kg). A marked heterogeneity in the failure rate in all treatment groups was observed across participating centers. Adverse events, including overall thromboembolic events, were comparable between groups. Conclusion: Treatment with rFVIIa had no significant effect on the primary composite endpoint compared with placebo. Therefore, decision on the use of this hemostatic agent in acute variceal bleeding should be carefully considered, because results of this study do not support the routine use of rFVIIa in this setting. Adverse events were comparable across groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
(2001) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,461
Hemostasis and Thrombosis: Basic Principles and Clinical Practice.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-504_7 · Cited by 1,854
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042991 · Cited by 1,167
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A. (2007) · Stroke · doi:10.1161/01.str.0000254499.46122.22 · Cited by 1,034
Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic Indicators
D'Amico, G., & De Franchis, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50385 · Cited by 907
Self-citationImproved survival after variceal bleeding in patients with cirrhosis over the past two decades
Carbonell, N., Pauwels, A., Serfaty, L., Fourdan, O., Lévy, V. G., & Poupon, R. (2004) · Hepatology · doi:10.1002/hep.20339 · Cited by 842
Self-citationTripodi, A., Salerno, F., Chantarangkul, V., Clerici, M., Cazzaniga, M., Primignani, M., & Mannuccio Mannucci, P. (2005) · Hepatology · doi:10.1002/hep.20569 · Cited by 696
Section XXIV. Partition Chromatographs
(2009) · Biotechnology · doi:10.1201/9781420084498-31 · Cited by 590
Garcia–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 471
Cited by
Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Self-citationThe Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011170 · Cited by 1,342
Management of Varices and Variceal Hemorrhage in Cirrhosis
Garcia-Tsao, G., & Bosch, J. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901512 · Cited by 951
Self-citationManagement of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
Levi, M., Levy, J. H., Andersen, H. F., & Truloff, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006221 · Cited by 677
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Acute-on chronic liver failure
Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., Arroyo, V., & Kamath, P. S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.026 · Cited by 646
A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding
Reverter, E., Tandon, P., Augustin, S., Turon, F., Casu, S., Bastiampillai, R., Keough, A., Llop, E., González, A., Seijo, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.018 · Cited by 402
Self-citationHemostasis and thrombosis in patients with liver disease: The ups and downs
Lisman, T., Caldwell, S. H., Burroughs, A. K., Northup, P. G., Senzolo, M., Stravitz, R. T., Tripodi, A., Trotter, J. F., Valla, D.-C., & Porte, R. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.042 · Cited by 360
Villa, E., Bianchini, M., Blasi, A., Denys, A., Giannini, E. G., de Gottardi, A., Lisman, T., de Raucourt, E., Ripoll, C., & Rautou, P.-E. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.003 · Cited by 318
Hypercoagulability in cirrhosis: causes and consequences
TRIPODI, A., ANSTEE, Q. M., SOGAARD, K. K., PRIMIGNANI, M., & VALLA, D. C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04429.x · Cited by 295
Gralnek, I. M., Camus Duboc, M., Garcia-Pagan, J. C., Fuccio, L., Karstensen, J. G., Hucl, T., Jovanovic, I., Awadie, H., Hernandez-Gea, V., Tantau, M., et al. (2022) · Endoscopy · doi:10.1055/a-1939-4887 · Cited by 283
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
Zipprich, A., Garcia‐Tsao, G., Rogowski, S., Fleig, W. E., Seufferlein, T., & Dollinger, M. M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02830.x · Cited by 280
Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
Ratziu, V., & Friedman, S. L. (2023) · Gastroenterology · doi:10.1053/j.gastro.2020.05.046 · Cited by 88
Metadata
- Authors
- Bosch, J., Thabut, D., Albillos, A., Carbonell, N., Spicak, J., Massard, J., D'Amico, G., Lebrec, D., de Franchis, R., Fabricius, S., Cai, Y., & Bendtsen, F.
- Venue
- Hepatology
- Published
- 2008-05
- Volume
- 47
- Issue
- 5
- Pages
- 1604-1614
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1978745785
- Cited by
- 303
- References
- 23
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.